The Emerging Role of N-Acetylaspartate in Cancer
International Journal of Molecular Sciences · 08.07.2026 · 27 (14) · 6105
DOI: 10.3390/ijms27146105 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.07.2026. Verfasst von Yongzi Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: West China Centre of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China-Liverpool Biomedical R…. Hauptthemen laut MEDLINE: Aspartic Acid, Neoplasms. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province, Health Commission of Sichuan Province Medical Science and Technology.
Abstract (Originalsprache)
N-Acetylaspartate (NAA), historically considered a brain-restricted neuro-metabolite, has emerged as a pivotal regulator in cancer biology. Governed by the biosynthetic enzyme N-acetyltransferase 8-like (NAT8L), the NAA axis exerts notable biological effects in malignancies. This review delineates the NAA axis as a context-dependent metabolic rheostat that is strategically hijacked by malignancies to orchestrate growth and immune evasion. Rather than a passive bystander, the NAA axis functions through distinct, histology-specific paradigms: it either serves as a metabolic reservoir to fuel lipid biomass expansion or is suppressed to redirect aspartate flux toward nucleotide biosynthesis, depending on the tumor’s unique genetic and metabolic bottlenecks. Beyond cell-intrinsic reprogramming, tumor-derived NAA is increasingly linked to immune evasion by impairing cytotoxic lymphocyte function and driving pro-tumorigenic M2-like macrophage polarization. By reconciling these disparate oncogenic roles, this review highlights the NAA axis as an important node of metabolic plasticity and evaluates its potential utility as a circulating biomarker and a stratifiable therapeutic target in diverse human malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- West China Centre of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu 61004…
- West China Biobank, West China Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Wei Huang
Förderung
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
- Health Commission of Sichuan Province Medical Science and Technology
Zitieren
APA
Wu, Y., Luo, W., Yao, L., Huang, W., & Liu, S. (2026). The Emerging Role of N-Acetylaspartate in Cancer. International Journal of Molecular Sciences, 27(14), 6105. https://doi.org/10.3390/ijms27146105
Vancouver
Wu Y, Luo W, Yao L, Huang W, Liu S. The Emerging Role of N-Acetylaspartate in Cancer. International Journal of Molecular Sciences. 2026;27(14):6105. doi:10.3390/ijms27146105
BibTeX
@article{Wu2026,
author = {Wu, Yongzi and Luo, Wenjuan and Yao, Linbo and Huang, Wei and Liu, Shiyu},
title = {The Emerging Role of N-Acetylaspartate in Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6105},
doi = {10.3390/ijms27146105}
}
EUVIMED